A detailed history of Stephens Consulting, LLC transactions in Cerus Corp stock. As of the latest transaction made, Stephens Consulting, LLC holds 1,575 shares of CERS stock, worth $2,709. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,575
Previous 1,583 0.51%
Holding current value
$2,709
Previous $3.42 Million 12.95%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 17, 2024

SELL
$1.66 - $2.42 $13 - $19
-8 Reduced 0.51%
1,575 $2.98 Million
Q1 2023

Apr 19, 2023

BUY
$2.65 - $3.81 $21 - $30
8 Added 0.51%
1,583 $4.7 Million
Q4 2021

Jan 19, 2023

BUY
$5.97 - $7.93 $9,402 - $12,489
1,575 New
1,575 $10.7 Million

Others Institutions Holding CERS

About CERUS CORP


  • Ticker CERS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 177,090,000
  • Market Cap $305M
  • Description
  • Cerus Corporation operates as a biomedical products company. The company focuses on developing and commercializing the INTERCEPT Blood System to enhance blood safety. Its INTERCEPT Blood System, a proprietary technology for controlling biological replication that is designed to reduce blood-borne pathogens in donated blood components intended fo...
More about CERS
Track This Portfolio

Track Stephens Consulting, LLC Portfolio

Follow Stephens Consulting, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Stephens Consulting, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Stephens Consulting, LLC with notifications on news.